内镜逆行胰胆管造影术后胰腺炎的防治进展  

Progress in Prevention and Treatment of Post-ERCP Pancreatitis

作　　者：肖广远[1] 张静喆[1] 

机构地区：[1]上海中医药大学附属龙华医院普外科,上海200032

出　　处：《医学综述》2013年第1期144-146,共3页Medical Recapitulate

基　　金：国家教育部高等学校博士点基金(20113107110002);国家自然科学资金项目(81173267);上海市教委项目(2010JW36);上海市科委中药现代化专项(11DZ1972701)

摘　　要：经内镜逆行胰胆管造影术(ERCP)是肝胆胰疾病重要的诊治手段,尤其是治疗性ERCP在肝胆胰疾病的微创治疗中占有越来越重要的地位,已越来越多地应用于临床。因ERCP是有创技术,难免出现一些并发症,ERCP术后胰腺炎是常见的并发症,发生率较高,其发生主要与胰管显影、插管困难等诸多因素有关。虽然ERCP术后胰腺炎的防治方法很多,如术前预防用药、术中放置胰管支架、鼻胆管引流等,但ERCP术后胰腺炎的发生仍是困扰临床医师的一大难题,随着ERCP诊治技术的广泛开展,其防治已成为热点,近年取得了一定的进展。Endoscopic retrograde cholangiopancreatography （ERCP） is an important means of diagnosis and treatment of hepatobiliary and pancreatic diseases, especially that the therapeutic ERCP is playing an in- creasingly important role in the minimally invasive treatment of hepatobiliary and pancreatic diseases and is being increasingly applied in clinical practice, ERCP is an invasive technology thus inevitably leads to some complications such as post-ERCP pancreatitis（PEP） which has a high occurrence associated with pancreatic duct developing,difficult intubation, and other factom. Although there are methods to control PEP such as prophylaxis drug before surgery, placing a pancreatic duct stent, and nasobiliary drainage, the occurrence of PEP is still a major problem plaguing clinicians. With the ERCP diagnosis and treatment technology extensive development, PEP prevention has become a hot spot in recent years and has obtained some progress.

关 键 词：经内镜逆行性胰胆管造影术 胰腺炎 防治 

分 类 号：R657.4[医药卫生—外科学] R657.5[医药卫生—临床医学]